Infectious Pulmonary Endotheliopathy clinical trials

Explore recruiting infectious pulmonary endotheliopathy clinical trials.

Recruiting infectious pulmonary endotheliopathy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Infectious Pulmonary Endotheliopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

“Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in mechanically ventilated patients with infectious pulmonary endotheliopathy – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial” (COMBAT-ARF).

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Infectious Pulmonary Endotheliopathy trials by city

Infectious Pulmonary Endotheliopathy in Toronto Infectious Pulmonary Endotheliopathy in Vancouver Infectious Pulmonary Endotheliopathy in Montreal Infectious Pulmonary Endotheliopathy in Calgary Infectious Pulmonary Endotheliopathy in Edmonton Infectious Pulmonary Endotheliopathy in Ottawa Infectious Pulmonary Endotheliopathy in Winnipeg Infectious Pulmonary Endotheliopathy in Quebec City Infectious Pulmonary Endotheliopathy in Hamilton Infectious Pulmonary Endotheliopathy in Kitchener Infectious Pulmonary Endotheliopathy in London Infectious Pulmonary Endotheliopathy in Halifax Infectious Pulmonary Endotheliopathy in New York Infectious Pulmonary Endotheliopathy in Los Angeles Infectious Pulmonary Endotheliopathy in Chicago Infectious Pulmonary Endotheliopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease